Correlation Between Eupraxia Pharmaceuticals and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Inhibrx, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Inhibrx.
Diversification Opportunities for Eupraxia Pharmaceuticals and Inhibrx
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Eupraxia and Inhibrx is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Inhibrx go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Inhibrx
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to under-perform the Inhibrx. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eupraxia Pharmaceuticals is 1.17 times less risky than Inhibrx. The pink sheet trades about -0.03 of its potential returns per unit of risk. The Inhibrx is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 2,457 in Inhibrx on August 31, 2024 and sell it today you would lose (931.00) from holding Inhibrx or give up 37.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 66.84% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Inhibrx
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Inhibrx |
Eupraxia Pharmaceuticals and Inhibrx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Inhibrx
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Eliem Therapeutics |
| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |